Table 4.
EG1000 (n = 37) |
EG500 (n = 32) |
Placebo (n = 28) |
||||
---|---|---|---|---|---|---|
Baseline | Six months | Baseline | Six months | Baseline | Six months | |
Without OS | 5 (13%) | 13 (35%) * | 3 (10%) | 9 (28%) * | 6 (21%) | 2 (7%) * |
Mild OS | 14 (38%) | 18 (49%) | 19 (59%) | 15 (47%) | 12 (43%) | 8 (29%) * |
Moderate OS | 10 (27%) | 5 (13%) * | 9 (28%) | 8 (25%) | 8 (29%) | 15 (54%) * |
Severe OS | 8 (22%) | 1 (3%) * | 1 (3%) | 0 (0%) | 2 (7%) | 3 (10%) |
OS: oxidative stress. McNemar test, * p < 0.05 baseline vs. after six months.